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Abstract
Aims: Preoperative proteinuria is associated with post-operative acute kidney injury (AKI), but whether it is also associated
with increased long- term mortality and end -stage renal disease (ESRD) is unknown.
Methods and Results: We studied 925 consecutive patients undergoing CABG. Demographic and clinical data were
collected prospectively, and patients were followed for a median of 4.71 years after surgery. Proteinuria, according to
dipstick tests, was defined as mild (trace to 1+) or heavy (2+ to 4+) according to the results of the dipstick test. A total of
276 (29.8%) patients had mild proteinuria before surgery and 119 (12.9%) patients had heavy proteinuria. During the
follow-up, the Cox proportional hazards model demonstrated that heavy proteinuria (hazard ratio [HR], 27.17) was an
independent predictor of long-term ESRD. There was a progressive increased risk for mild proteinuria ([HR], 1.88) and
heavy proteinuria ([HR], 2.28) to predict all–cause mortality compared to no proteinuria. Mild ([HR], 2.57) and heavy
proteinuria ([HR], 2.70) exhibited a stepwise increased ratio compared to patients without proteinuria for long–term
composite catastrophic outcomes (mortality and ESRD), which were independent of the baseline GFR and postoperative
acute kidney injury (AKI).
Conclusion: Our study demonstrated that proteinuria is a powerful independent risk factor of long-term all-cause mortality
and ESRD after CABG in addition to preoperative GFR and postoperative AKI. Our study demonstrated that proteinuria
should be integrated into clinical risk prediction models for long-term outcomes after CABG. These results provide a high
priority for future renal protective strategies and methods for post-operative CABG patients.
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Introduction
Although coronary artery bypass grafting (CABG) surgery can
result in improved quality and prolongation of life in selected
patients, several factors have been identified as independent
predictors of poor outcomes [1]. The pre-operative estimated
glomerular filtration rate (eGFR) is one of the most powerful
predictors of CABG outcome [2,3]. In addition, even a mild
elevation of serum creatinine after surgery carries a significant risk
of adverse outcomes [4].
Based on experience with chronic kidney disease (CKD),
proteinuria (detected either by dipstick tests or the albumin-
creatinine ratio [ACR]) has been shown to be strongly associated
with adverse outcomes, including incident acute kidney injury
(AKI), renal disease progression, cardiovascular events, and long-
term mortality in the general population [5–8]. Recent reports
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proteinuria have a higher risk of adverse outcomes than those
without proteinuria at the same stage of CKD [9,10]. It has been
suggested that GFR and proteinuria should be used together to
identify patients at risk [5,9–11]. Screening for proteinuria is a
better strategy than relying on a low eGFR to identify individuals
who are at risk for accelerated GFR loss in population screening
[12]. Furthermore, the episode of AKI could provide further long-
term prognostic information in addition to eGFR and proteinuria
[11]. We previously reported that pre-operative proteinuria,
independent of pre-operative eGFR and other co-morbidities,
could predict AKI in patients undergoing CABG [13]. No study
has shown pre-operative proteinuria to be an independent risk
factor of long-term mortality and dialysis dependence in post-
CABG patients with a high mortality rate.
The objective of this study was to estimate the post-discharge,
long-term mortality, and ESRD risk associated with pre-operative
proteinuria, while adjusting for pre-operative eGFR with post-
operative AKI and other co-morbidities in post-CABG patients.
Results
Among the 1136 adult patients who underwent CABG during
the period from January 2003 to December 2006, 50 patients had
undergone dialysis before surgery, 30 patients were CKD stage 5
before surgery, and 76 patients did not have urinalysis measure-
ments before surgery. During the hospital admission, 55 patients
expired. Therefore, only 925 patients were included in the final
analysis (Figure S1).
Patients with impaired renal function (low eGFR or
proteinuria; Table 1, 2)
Three hundred nineteen patients (34.5%) were classified as CKD
stage 3, while 52 (5.6%) patients were classified as stage 4 pre-
operatively. The patients with higher CKD stages (stages 3 and 4)
were older and had higher Charlson scores, lower pre-operative Hb
levels, required more tracheostomies, had more post-cardiac surgery
AKI than patients with preserved kidney function. Patients with stage
4 CKD were more likely to have PAD, undergo CPB, and required
post-operative RRT than patients with preserved kidney function.
A total of 276 (29.8%) patients had mild proteinuria before
surgery and 119 (12.9%) patients had heavy proteinuria. Those with
proteinuria were more likely to have DM, impaired left ventricular
contractility, CHF, and post-operative AKI. These patients also had
significantly lower eGFRs, higher Charlson scores, and lower pre-
operative hemoglobin (Hb) levels than non-proteinuric patients.
PatientswithheavyproteinuriaweremorelikelytohavePAD,CVA,
tracheostomies, receive CPB, and require post-operative RRT.
In patients with preserved eGFR, 147 (15.9%) patients had mild
proteinuria and 34 (3.7%) patients had heavy proteinuria. In stage
3 CKD patients, 11 (15.6%) had mild proteinuria and 65 (18.1%)
had heavy proteinuria, and in stage 4 patients, 12 (4.3%) had mild
proteinuria and 27 (22.7%) had heavy proteinuria (Table S1).
Long-term adverse outcomes were stratified by CKD stage and
the severity of proteinuria (Table 3). Patients with preserved eGFR
and without proteinuria had the lowest rates of post-operative
RRT (0.3%), mortality (5.6%), and composite outcomes (5.9%).
The severity of proteinuria showed a dose response-type increased
risk for adverse long-term outcomes in patients with preserved
eGFR, and CKD stage 3, but not in patients with CKD stage 4.
ESRD after CABG (Table 4, Fig. 1)
During follow-up, the total incidence of ESRD was 0.2, 1.1, and
5.5 per 100 person–years among surviving hospital patients with
pre-operative normal, mild, and heavy proteinuria, respectively.
We included the variables listed in Table 1, 2 into regression
analysis to identify significant factors associated with post-
operative ESRD. CKD stages were representative of pre-operative
renal function, as stated in the Methods. The Cox proportional
hazards model demonstrated heavy proteinuria (HR, 27.17) and
CKD stage 4 (HR, 91.21) as independent predictors of long-term
ESRD (Table S2). The interaction term between CKD and
proteinuria (p,0.001) was inverse related to long-term ESRD.
The magnitude of the increases associated with ESRD grew
progressively with heavier baseline proteinuria. (HR=5.282,
p,0.001 for trend)
All-cause mortality after CABG (Table 4, Fig. 2)
The incidence for all-cause mortality was 1.9, 5.1, and 8.0 per
100 person–years among patients with normal, mild, and strong
proteinuria, respectively.
We also put all the variables listed in Table 1, 2 into regression
analysis for identifying important risk factors of post-operative
mortality. In the final model, there was a progressive increased risk
of mild proteinuria (HR, 1.88) and heavy proteinuria (HR, 2.28) to
predict all–cause mortality in addition to CKD stages and
postoperative AKI. (Table S3). The other significant factors of
long-term mortality were older age, low LVEF, a history of CAD,
absence of HTN, and post-operative RRT requirements.
The interaction term between CKD and proteinuria was not
significant (p.0.05). (Table S3). The test for linear trend across
proteinuria categories was significant. (HR=1.542 , p,0.001).
Post-operative long-term composite outcomes
HRs for long–term composite outcomes associated with the
CKD and proteinuria categories are shown in Fig. 3. Patients with
mild (HR, 2.57) and heavy proteinuria (HR, 2.70) and patients
with CKD stage 3 (HR, 2.24) and stage 4 (HR, 3.52) had a
stepwise increased ratio compared to patients without proteinuria
or patients with preserved eGFR stages (Table S4).
HRs were obtained using Cox proportional hazards regression
for categorical analysis and adjusted for factors listed in Table 1, 2
with CKD stages as representative of pre-operative kidney
function (Fig. 4). Figure 4a showed survival curves for proteinuria
categories across eGFR categories. The HRs for long-term
composite outcome increased with the severity of proteinuria
(Figure S2), and also increased with CKD stages. Both CKD stages
and postoperative AKI modified the frequency and consequences
of proteinuria status. (Figure 4b) The HR for composite outcome
was the highest with heavy proteinuria strata within stage 4 CKD
(HR, 11.58; 95% CI, 5.20–26.70; p,0.001). The risk for
composite outcome was magnified further when mild proteinuria
was present in those with baseline stage 4 CKD (HR, 9.9; 95% CI,
4.83–20.30; p,0.001) compared to patients with a preserved
CKD stage without proteinuria. The magnitude of the increases
associated with composite outcome grew progressively with
heavier baseline proteinuria. (HR=1.649 , p,0.001 for trend).
Several sensitivity analyses were undertaken. We compared the
characteristics of the 76 patients without pre-operative urinalysis
with the patients included in the data analysis. Similar results were
noted with respect to age (p=0.870), gender (p=0.799), CKD
stages (p=0.786), DM (p=0.250), long-term ESRD (p=0.999),
long-term mortality (p=0.327), and long-tem composite outcome
(p=0.647). DM had an additive interaction with CKD stages in
predicting long-term mortality. Because of this, we repeated our
logistic regression model stratified by diabetes status. Heavy
proteinuria was associated with an even greater risk of mortality
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e27687among patients with diabetes (HR, 3.34) than among those
without (HR, 1.88) diabetes.
Discussion
We have found that proteinuria is potentially a risk factor of
postoperative adverse outcome; however, this simple test is usually
neglected in current practice. These findings should make
clinicians more concerned about the presence of low quantities
of protein in the urine. Our study is the first report to show a
marked impact of proteinuria at the time of CABG on long-term
mortality and ESRD prediction in post-CABG patients. The
National Kidney Foundation staging system for CKD incorporates
proteinuria only in the preserved eGFR stages (CKD stages 1 and
2). An association between proteinuria and long- term mortality or
ESRD after cardiac surgery has not yet been validated. We
showed that proteinuria is associated with a higher risk of long-
term ESRD and mortality; even mild proteinuria could predict
long- term adverse outcomes. This association was essentially
unaltered despite extensive statistical adjustment for traditional
CABG risk factors, including chronic kidney disease, AKI, or
diabetes mellitus. This adds weight to the growing body of
evidence that proteinuria should be considered a high risk
condition and that this risk is in addition to any risk attributable
to reduced eGFR [5].
The results clearly demonstrated that pre-operative proteinuria
is an important, yet neglected predictor for long-term composite
outcomes after cardiac surgery. However, the current widely used
prognostic scoring systems do not use proteinuria [14]. Preventive
interventions have been most studied in patients at high risk
because high-risk patients benefit more from such interventions
than low-risk patients [15]. Thus, it is very important to develop
an inclusive and accurate staging system, especially for patients
who are undergoing a procedure associated with significant risks,
such as cardiac surgery. Also, this is the first report to systemically
investigate the relationship between proteinuria and post-operative
long –term renal outcomes and demonstrate the strong association
with adverse renal outcomes.
Risk for ESRD according to severity of proteinuria
We have previously reported heavy proteinuria, regardless of
baseline eGFR or other co-morbidities, to be independently
associated with severe AKI requiring RRT after cardiac surgery
[13]. Proteinuria reflects a size-selective dysfunction of the
glomerular barrier usually associated with a decline in the GFR
that may result in ESRD [16]. There is some evidence that overt
albuminuria might be associated with tubulointerstitial damage.
Patients with documented proteinuria have less physiologic
adaptability and are less able to tolerate kidney hemodynamic
changes and other nephrotoxic insults [17].
In a previous population-based cohort study, macroalbuminuria
is a better risk marker than low eGFR to identify population
screening of individuals who are at risk for accelerated GFR loss
[12]. In fact, our CABG patients with preserved kidney function
and positive dipstick proteinuria have a greater risk for having a
composite outcome than patients with stage 3 CKD and without
proteinuria detected by dipstick.
Table 1. Patients’ demographics, classified by CKD stages or proteinuria.
CKD Stage Proteinuria on dipstick
All (n=925) Preserved eGFR Stage 3 Stage 4 Normal Mild Heavy
(n=554) (n=319) (n=52) (n=530) (n=276) (n=119)
Patient characteristics
Gender (male) 75.9% 82.3% 69.6%*** 46.2%*** 79.2% 75.7% 61.3%***
Age (years) 65.9610.9 63.5611.3 69.668.6*** 69.0610.9*** 65.1611.4 67.369.9* 66.2610.1
Body mass index (kg/m
2) 25.063.7 25.163.3 25.164.2 24.363.8 25.163.4 25.464.2 24.263.5
Charlson score 1.861.8 1.561.5 2.262.0*** 3.361.6*** 1.561.5*** 2.061.9*** 3.062.2***
LVEF,60% 46.9% 42.1% 49.8%* 80.8%*** 40.8% 51.1%** 64.7%***
Hypertension 69.2% 65.9% 74.6%** 71.2% 68.1% 69.9% 72.3%
DM 43.4% 38.4% 48.6%** 63.5%*** 34.9% 44.6%** 78.2%***
PAD 9.0% 6.9% 9.4% 28.8%*** 6.4% 8.3% 21.8%***
CVA 9.9% 8.8% 11.0% 15.4%* 7.9% 11.6% 15.1%*
CHF 15.9% 11.2% 19.4%*** 44.2%*** 10.4% 19.2%*** 32.8%***
COPD 8.1% 7.6% 9.4% 5.8% 7.2% 11.2% 5.0%
Recent MI 26.3% 24.0% 28.5% 36.5% 23.4% 32.2%** 25.2%
Af 6.6% 5.4% 9.4%* 1.9% 5.1% 8.7% 8.4%
Peri-operative condition
Vasopressor dependence 3.6% 2.7% 4.2%* 9.7%** 2.2% 5.7%
** 5.1%
Tracheostomy 2.2% 1.1% 3.4%* 5.8%* 0.9% 2.5% 6.7%***
Non-elective surgery 10.5% 9.4% 11.7% 13.5% 6.8% 15.4%*** 15.1%**
Cardiopulmonary bypass 13.6% 12.5% 14.1% 23.1%* 11.3% 15.9% 18.5%*
AKI 15.1% 9.9% 20.4%*** 38.5%*** 9.6% 19.6%*** 29.4%***
RRT 3.6% 2.0% 3.5% 22.4%*** 1.5% 2.2% 16.4%***
doi:10.1371/journal.pone.0027687.t001
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We found the association between eGFR and mortality differed
by severity of proteinuria. Decreased eGFR and increased
proteinuria independently contributed to the cumulative proba-
bility of all-cause mortality and the risk persisted after full
multivariable adjustments, including post-operative AKI. Previous
studies have demonstrated that AKI is associated with increased
long-term mortality after cardiothoracic surgery, even with a small
change in serum creatinine [18]. Further, pre-operative protein-
uria and CKD stages, independent of post-operative AKI, are
associated with an increased risk of long–term mortality.
When the analysis focused on post-operative composite outcome,
patients with impaired eGFR and proteinuria were found to have a
greater risk than those without proteinuria. Even mild proteinuria
(trace to 1+) increased the risk of a patient with stage 3 CKD to the
same risk as stage 4 CKD (Figs. 4). Most strikingly, patients with
preserved GFR ($60 mL/min/1.73 m
2) had a risk comparable to
stage 3 CKD, if mild proteinuria (trace to 1+) was present (Fig. 4).
These categories of patients have previously been neglected, even
though they made up 32.7% (181 of 554 patients) of our cohort.
This means that one-third of patients undergoing CABG surgery,
who are at an increased risk of long-term mortality and ESRD, are
not identified by the current risk scoring systems based only on sCr
or GFR measurements. On the other hand, the absence of an
interaction effect of CKD and proteinuria in the prediction of long-
term mortality was notable because a very small amount of protein
Table 2. Operative characteristics and renal function, classified by CKD stages or proteinuria.
CKD Stage Proteinuria on dipstick
All (n=925) Preserved eGFR Stage 3 Stage 4 Normal Mild Heavy
(n=554) (n=319) (n=52) (n=530) (n=276) (n=119)
CABG parameters
Aortic cross clamp time(min),(n) 1036 41 (31) 826 36 (15) 1016 58 (13) 1026 23 (3) 1056 65 (12) 108636 (14) 976 25 (5)
Cardiopulmonary bypass(min),(n) 1256 53 (130) 127651 (75) 1236 71 (42) 1276 41 (13) 1256 60 (60) 1286 63 (48) 1206 32 (22)
Triple vessel disease 93.4% 81.2% 86.2% 88.5% 81.7% 87.0% 92.4%
Left main diseases 37.8% 38.8% 35.4% 42.3% 37.5% 42.0% 29.4%
IABP 9.1% 7.8% 11.0% 11.5% 7.7% 10.9% 10.9%
Preoperative IABP 7.4% 6.1% 9.4% 7.7% 5.5% 9.4% 10.9%
ECMO 1.2% 0.9% 1.3% 3.8% 0.6% 2.2% 1.7%
Mitral insufficiency
Mild 18.9% 19.9% 17.2% 19.2% 19.1% 20.7% 14.3%
Moderate/severe 8.6% 7.6% 8.2% 23.1%*** 5.8% 9.4% 19.3%
Pre-operative laboratory data
Creatinine (mg/dL) 1.360.5 1.060.2 1.560.3*** 2.660.55*** 1.1260.4 1.360.4** 1.760.7***
eGFR(ml/min/1.73 m
2) 64.4621.1 77.6614.6 48.1268.4*** 23.2264.02*** 69.618.7 62.3621.2*** 48.10622.0***
Hemoglobin (g/dL) 12.961.9 13.461.6 12.562.06*** 10.961.8*** 13.261.8 12.861.9* 11.961.9***
Comparison with patients with preserved estimated GFR ($60 ml/min/1.73 m
2) or no proteinuria: *p,0.05; **p,0.01; and ***p,0.001.
Abbreviations; CABG: coronary artery bypass grafting surgery; CKD: chronic kidney disease; eGFR: estimated glomerular filtrating rate; ESRD: end stage renal disease.
doi:10.1371/journal.pone.0027687.t002
Table 3. Adverse outcomes in 925 CABG patients with various CKD stages and degrees of proteinuria.
Outcomes ESRD (n=41) p
b Mortality (n=138) p
b Composite outcome (n=164) p
b
Proteinuria
CKD Stages Normal Mild Heavy Normal Mild Heavy Normal Mild Heavy
Preserved
eGFR
0.3% 1.4% 11.8% ,0.001 5.6% 15.6% 14.7% 0.001 5.9% 17.0% 26.5% ,0.001
(n=554)
Stage 3 1.4% 2.6% 17.2% ,0.001 15.3% 24.8% 34.5% 0.009 16.7% 26.5% 43.1% ,0.001
(n=319)
Stage 4 23.1% 58.3% 38.5% 0.195 30.8% 41.7% 48.1% 0.580 46.2% 75.0% 66.7% 0.288
(n=51)
p
a ,0.001 ,0.001 0.028 ,0.001 0.035 0.018 ,0.001 ,0.001 0.007
Abbreviations; CABG: coronary artery bypass grafting surgery; CKD: chronic kidney disease; eGFR: estimated glomerular filtrating rate; ESRD: end stage renal disease.
p: The tests for linear trend across CKD categories (p
a) and across proteinuria categories (p
b). Composite outcome: composite outcome of end stage renal disease and
mortality. To be noted, 15 patients of them received chronic dialysis before mortality.
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CKD patients [19]. These findings should motivate clinicians to
become more concerned about the presence of low quantities of
protein in the urine.
A previous small study about CABG showed proteinuria is
factor to affect long-term cardiovascular death [20]. However,
CKD was not a risk factor in their study. Bouts of evidence show
the pre-operative estimated glomerular filtration rate (eGFR) is
Table 4. Factors associated with long- term adverse outcomes (N=925).
Hazard Ratio(95% CI) ESRD all cause mortality composite outcome
Covariate Unadjusted adjusted Unadjusted adjusted Unadjusted adjusted
Proteinuria
No proteinuria 1— — — — —
(reference)
Mild proteinuria 3.93 2.83 2.29 1.88 2.42 2.70
(1.48–10.40)** (1.01–7.99)* (1.55–3.39) *** (1.27–2.80)* (1.67–3.49) *** (1.69–4.33)***
Heavy proteinuria 10.10 27.17 2.65 2.28 3.36 2.57
(3.98–25.73)*** (8.77–84.15)** (1.68–4.18)*** (1.42–3.66)** (2.23–5.06) *** (1.68–3.91)***
CKD Stage
Preserved CKD stage 1— — — — —
(reference)
Stage 3 3.29 10.71 2.35 1.53 2.33 2.24
(1.32–8.15)* (0.93–123.2) (1.62–3.41) *** (1.20–2.28)* (1.64–3.30) *** (1.40–3.57)***
Stage 4 35.52 91.21 4.85 1.88 7.35 3.52
(14.25–88.52)*** (31.05–267.94)*** (2.83–8.33) *** (1.03–3.43)* (4.65–11.63)*** (2.09–5.94)***
Abbreviations: CI: confidence interval; CKD: chronic kidney disease.
The long- term adverse outcome uses the Cox’s proportional hazard model adjusted for age, genders, admission conditions including CKD stage, postoperative acute
kidney injury, renal replacement therapy, co-morbidities (hypertension, liver cirrhosis, congestive heart failure, diabetic mellitus, chronic obstructive pulmonary disease ,
coronary artery disease, hepatitis, cancer, atrial fibrillation), Carlson score, intervention (extracorporeal membrane oxygenation, Ventilator, intra-aortic balloon pumping,
use intra-cerebral pressure monitor, Mitral insufficiency, temporary cardiac pacemaker, Swan- Ganz catheter, Sengstaken-Blakemore tube).
*p,0.05;
**p,0.01; and
***p,0.001.
doi:10.1371/journal.pone.0027687.t004
Figure 1. Proportion of freedom from long- term dialysis dependence, stratified by different severities of proteinuria defined by
preoperative dipstick. (Mild proteinuria, p=0.166; Heavy proteinuria, p=0.001; No proteinuria was the reference calculated by multivariable Cox
proportional hazard analyses).
doi:10.1371/journal.pone.0027687.g001
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addition, we report that proteinuria is a powerful independent risk
factor of long-term all-cause mortality and ESRD after CABG in
addition to preoperative GFR.
The association between higher CKD stages and higher long-
term cumulative composite outcomes increased significantly with
an increased severity of proteinuria. In linear trend analysis, the
severity of proteinuria showed a dose response-type increasing risk
for long-term outcomes in patients with preserved eGFR, and
CKD stage 3, but not for stage 4. ( please see table 3). However, in
multivariable model the HRs for long-term composite outcome
increased with the severity of proteinuria (Figure S2), and also
Figure 2. Adjusted risk for long- term all- cause mortality after hospital discharge stratified by different severities of proteinuria
defined by preoperative dipstick. (Mild porteinuria, p=0.005; Heavy proteinuria, p=0.008; no proteinuria was the reference calculated by
multivariable Cox proportional hazard analyses).
doi:10.1371/journal.pone.0027687.g002
Figure 3. Proportion of freedom from long- term composite outcome after hospital discharge, composite outcome of ESRD and
mortality, stratified by different severities of proteinuria defined by preoperative dipstick. (Mild proteinuria, p,0.001; Heavy
proteinuria, p,0.001; No proteinuria was the reference calculated by multivariable Cox proportional hazard analyses).
doi:10.1371/journal.pone.0027687.g003
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participants with and without a history of DM in sensitivity
analysis and this result could enhance the joint effects of
proteinuria and CKD stages.
Pre-operative proteinuria is not only a marker of chronic renal
insults, but may also serve as a surrogate of organ damage. Patients
with more severe proteinuria had higher Charlson scores. In our
analysis, patients with more severe proteinuria had poor cardiac
contractility, DM, PAOD, and CHF, which implies that these
patients actually have renal damage and proteinuria secondary to
other extra-renal insults. Proteinuria may not just be a marker for
adverse outcomes. In vitro studies have demonstrated that exposure
of renal proximal tubule cells to albumin induced an inflammatory
cytokine cascade [21,22]. These events ultimately lead to
tubulointerstitial inflammation and fibrosis in long-standing
proteinuric nephropathy. The strong predictive effects of protein-
uria within 2 days before surgery and the simplicity of its
measurements suggest that periodic measurement of proteinuria
along with other major CVD risk factors should be considered in
long-term follow-up of post CABG patients. Whether or not
medications that decrease proteinuria might also be associated
with a decrease in mortality in persons undergoing CABG is an
important question to be addressed in future studies.
In a large community –based cohort of adults, the risk of long –
term mortality composite renal outcome increased substantially
with the presence and severity of proteinuria, in addition to reduced
eGFR [11]. Similarly, outcomes associated with post CABG AKI
have focused on definitions incorporating in proteinuria, magnitude
of increase in serum creatinine [13]. Our CABG patients also
provide ausefuldemonstrationofthe burdenofpost-operative AKI.
(fig. 4b) This disorder was more likely to prognosis to mortality and
composite outcomes during long-term follow-up and was substan-
tially more common at low GFR and with heavy proteinuria.
Study strengths and limitations
The strength of this study was that it assessed the outcomes in a
large cohort of patients undergoing CABG in multiple centers.
Therefore, the results are likely to be widely applicable. The study
population of CABG patients without severe CKD provided a well-
defined and homogenous study population in the present study.
There were some limitations to the current study that should be
considered. First, detection of proteinuria was performed with
dipsticks. In addition, the differences between the dipstick test and
ACR in risk assessment of long-term outcomes were not examined
in the current study. The epidemiologic studies on this topic either
used a dipstick test for proteinuria [11] or quantitatively measured
albuminuria. Of note, the urine dipstick examination is inexpensive
and readily performed and interpreted. These two tests were well-
correlated [23] and the dipstick test is useful for risk stratification
despite being a less precise measure of albuminuria in general
population cohorts [24,25]. Second, the absence of data on the
specific cause of mortality, such as myocardial infarction and heart
failure could be a limitation, thus we used all-cause mortality as the
primary end point, which is entirely objective [26]. Finally, we
assumed that the baseline covariates persisted throughout the
follow-up period. Additional assessments would be desirable,
especially to evaluate risks that vary over time. Increased numbers
of outcome events, including cause-specific mortality and incident
ESRD, will buttress the conclusions presented herein.
The present study demonstrated that proteinuria, detected by
urine dipstick test, is a powerful independent risk factor for long-
term composite outcomes (all-cause mortality and ESRD) in post–
Figure 4. The composite outcome after hospital discharge (long- term end-stage renal disease or mortality) for urinary proteinuric
categories across chronic kidney disease (CKD) categories using Cox proportional hazards regression (a) plot of freedom from
composite outcome,
*p,0.05;
**p,0.01; and
***p,0.001 compared to patients with preserved eGFR and normal proteinuria.
(b) Hazard ratio (HRs) stratified by proteinuria, baseline kidney function, and postoperative acute kidney injury (AKI) adjusted for factors listedi n
Table 1. The horizontal bars represent 95% CIs for HRs of participants who had proteinuria for various values of CKD stages and AKI.
doi:10.1371/journal.pone.0027687.g004
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term composite outcomes differed significantly across severity of
proteinuria. A further strength was that pre-operative proteinuria
in addition to pre-operative CKD stages and post-operative AKI is
associated with increased long–term mortality risk. A substantial
proportion of patients undergoing cardiac surgery have an
elevated risk of adverse outcomes that are not apparent from the
current risk scoring systems. This is an important insight for
physicians who care post-CABG patients, and further studies will
be needed to determine the optimal post-discharge follow-up of
renal function for patients with pre-operative proteinuria.
Methods
Study population
This is a secondary analysis of a prospectively-collected database.
Patients undergoing CABG surgery at the National Taiwan
University Hospital (NTUH) and its two branches between January
2003 and December 2006 were enrolled [27]. Inclusion criteria
were age $18 years and first-time cardiac surgery. The exclusion
criteria were a history of pre-operative renal replacement therapy
(RRT) with any modality and an estimated GFR,15 mL/min.
Patients with no urinalysis reports within 48 hours prior to surgery
were also excluded. Patient data collected from the NSARF
database included basic demographic characteristics, peri-operative
laboratory investigations, type and timing of surgery, and post-
operative renal outcome [27,28]. The goals of this study were to
evaluate the post-CABG long-term outcomes associated with
proteinuria. Patients undergoing pre-operative chronic dialysis,
stage 5 CKD, or death during the index hospital admission were
excluded. This study was approved by the Institutional Review
Board of National Taiwan University Hospital (NTUH)
(No. 31MD03). The informed consent was waived by the ethics
committee because there was no breach of privacy and it did not
interfere with clinical decisions related to patient care.
Clinical assessment of study patients
Pre-operative variables, such as age, gender, left ventricular
ejection fraction (LVEF) measured by ventriculography or
angiography, hypertension (HTN; blood pressure $140/
90 mmHg or using anti-hypertensive medications), diabetes
mellitus (DM; using oral hypoglycemic agents or insulin),
peripheral artery disease (PAD) determined by clinical diagnosis
or imaging results, previous cerebral vascular accident (CVA;
ischemic or hemorrhagic), New York Heart Association (NYHA)
functional class III or IV congestive heart failure (CHF), chronic
obstructive pulmonary disease (COPD) requiring long-term
bronchodilators or steroids, recent myocardial infarction (MI),
i.e., ,30 days before surgery, and pre-operative laboratory data
were all collected. Coronary artery disease (CAD) was defined as
the diagnosis of ischemic heart disease before admission and
positive electrocardiographic findings. Patients with associated
diseases were assessed using the Charlson co-morbidity score [29].
Peri-operative vasopressor (adrenaline, dopamine, dobutamine,
norepinephrine, or isoproterenol) dependence and use of extra-
corporeal membrane oxygenation (ECMO) or an intra-aortic
balloon pump (IABP) were noted. Patients who underwent
emergent or urgent surgical procedures were considered non-
elective surgery. Utilization of cardiopulmonary bypass (CPB) and
CPB duration during surgery was also recorded.
Pre-operative GFR and proteinuria
The following 3 parameters were used to represent pre-operative
GFR: serum creatinine, eGFR, and CKD stage (preserved eGFR,
stage 3 or 4, according to eGFR). The baseline serum creatinine
(sCr) was the datum obtained at hospital discharge from the
previous admission in those who had more than one admission
within 1 year before the index admission [30], or a pre-operative
creatinine obtained in pre-operative testing excluding the measure-
ments that were performed in the emergency department
[18,31,32]. The eGFR in each patient was calculated using the 4-
variable MDRD equation [33]. CKD stages were determined using
the NKF definition, as follows: 15 mL/min/m
2#eGFR,30 mL/
min/m
2 was classified as stage 4; and 30 mL/min/
m
2#eGFR,60 mL/min/m
2 was classified as stage 3. Patients
with an eGFR$60 mL/min/m
2 had preserved GFR.
Proteinuria was measured using a dipstick within 2 days before
surgery. To classify the severity of proteinuria, we defined negative
as ‘‘no proteinuria,’’ trace to 1+ as ‘‘mild proteinuria,’’ and 2+ to
4+ as ‘‘heavy proteinuria.’’ The test strips were measured by an
automatic dipstick autoanalyzer (AUTION MAX, AX-4030;
ARKRAY, Inc., Kyoto, Japan) with automatic correction of the
specific gravity using a pH test pad in a routine laboratory
environment. This classification was adopted in a large epidemi-
ologic study in Alberta, Canada [10]. Although ACR is favored for
detection of proteinuria, dipstick examination remains the most
convenient and inexpensive choice for screening [10]. If there
were more than one measurement in 2 days prior to surgery, we
chose the most severe result for analysis.
AKI and RRT
The definition of AKI was based on the Acute Kidney Injury
Network (AKIN) criteria, and has been well-validated in cardiac
surgery patients for in-hospital mortality prediction [34]. In the
NSARF database, sCr values were recorded daily after surgery.
Urine output was recorded every hour in the critical care setting.
Long-term mortality and dialysis dependence
The long-term outcomes for this analysis were mortality, ESRD,
and composite outcome (long–term ESRD or mortality) after
discharge. Patient survival after discharge was determined through
the databank of the National Health Insurance Research Database
(NHIRD) in January 2009 [35]. All-cause mortality was
documented by matching unique identity numbers with the
NHIRD.
The NHIRD contains health care data from .99% of the entire
population of 23.74 million in Taiwan, and it covers all inpatient
and outpatient medical benefit claims. We also cross–linked our
study population with the nationally comprehensive TAIWAN
Society Nephrology registry, which recorded all dialysis patients in
the island every 3 months.
Statistical analysis
Statistical analyses were performed with SPSS for Windows
(version 15.0; SPSS, Inc., Chicago, IL, USA). A two-sided p
value#0.05 was considered statistically significant. Continuous
variables were presented as the mean and standard deviation (mean
6 SD). Categorical variables were summarized as the frequency
and percentage. A group difference in demographic characteristics
was examined between each renal dysfunction group (CKD stages
or proteinuria) and the preserved renal function group by two-
sample t-test or chi-square test as appropriate.
The long-term outcomes were based on Cox’s proportional
hazard model adjusted for age, gender, admission categories,
CKD stage, post-operative AKI, RRT, co-morbidities (HTN, liver
cirrhosis, CHF, DM, COPD, CAD, hepatitis, cancer, and atrial
fibrillation (Af), Carlson score, intervention (ECMO, mechanical
ventilation, IABP, intra-cerebral pressure monitor (ICP), tempo-
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and a Sengstaken-Blakemore tube) and censored on 1 January
2009. Survival curves for all-cause mortality or freedom from
dialysis were generated from adjusted Cox models. Survival
models were initiated at the time of hospital discharge and
followed until death or last follow-up time. There was high
collinearity among sCr, estimated GFR (MDRD), and CKD stage,
so we adjusted the input variable of the CKD stage to be
representative of kidney function to emphasize the effect of pre-
operative kidney stage. Yet, there is a significant positive
relationship between the level of proteinuria and CKD stage
(p,0.001) and the risk of AKI might be different in patients with
and without DM [36]. Thus, the interaction effects between
proteinuria, CKD stages, postoperative AKI, and diabetics on
adverse outcomes were also considered.
For the long-term dialysis, an individual who survived at index
discharge was censored at death or at the end of the study period.
Hazard ratios (HRs) and 95% confidence intervals (CIs) were
derived from the Cox proportional hazard model. The incidence of
chronic dialysis and all-cause mortality were stratified for
participants with different severities of proteinuria. To help visualize
the analysis results, we investigated the relationship between the
effects of the level of CKD stages and severity of proteinuria by
adding interaction terms and plotted by fitting the basic Cox
regression analyses separately for the strata of the level of dipsticks.
Finally, sensitivity analyses were conducted. We compared the
basic demography and outcomes of the 76 patients without pre-
operative urinalysis with the study patients. A two-sided P
value,0.05 was considered to indicate statistical significance.
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